Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.335 EUR | -2.81% | -8.71% | -55.94% |
11:52am | EVOTEC : Deutsche Bank maintains a Buy rating | ZD |
May. 22 | Evotec Shares Rise Following Gene Therapy Exit, Q1 Results | MT |
Sales 2024 * | 876M 949M | Sales 2025 * | 1.03B 1.11B | Capitalization | 1.7B 1.85B |
---|---|---|---|---|---|
Net income 2024 * | -32M -34.69M | Net income 2025 * | 24M 26.02M | EV / Sales 2024 * | 2.25 x |
Net Debt 2024 * | 269M 292M | Net Debt 2025 * | 235M 255M | EV / Sales 2025 * | 1.89 x |
P/E ratio 2024 * |
-61.3
x | P/E ratio 2025 * |
36.6
x | Employees | 5,061 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.64% |
Latest transcript on Evotec SE
1 day | -2.76% | ||
1 week | -8.67% | ||
Current month | -3.70% | ||
1 month | -33.85% | ||
3 months | -32.95% | ||
6 months | -50.07% | ||
Current year | -55.92% |
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 23-02-06 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Roland Sackers
BRD | Director/Board Member | 56 | 19-06-18 |
Chairman | 63 | 14-06-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.68% | 17 M€ | -.--% | - | |
2.59% | 202 M€ | -.--% | ||
0.21% | 79 M€ | -.--% | ||
0.15% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 9.385 | -2.29% | 593 924 |
24-05-22 | 9.605 | +0.68% | 2,395,506 |
24-05-21 | 9.54 | -1.50% | 1,353,441 |
24-05-20 | 9.685 | -0.77% | 796,918 |
24-05-17 | 9.76 | -4.97% | 1,830,327 |
Delayed Quote Xetra, May 23, 2024 at 05:41 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.92% | 1.85B | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.21% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- EVT Stock